Loading chat...
US SB5459
Bill
AI Summary
Legislative Description
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Last Action
Read twice and referred to the Committee on Finance.
12/9/2024
Committee Referrals
Finance12/9/2024
Full Bill Text
No bill text available